AssetMark Inc’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$241K Sell
18,084
-381
-2% -$5.51K ﹤0.01% 1422
2026
Q2
$275K Buy
18,465
+1,392
+8% +$15K ﹤0.01% 1359
2026
Q1
$144K Sell
17,073
-2,866
-14% -$31.4K ﹤0.01% 1423
2025
Q4
$225K Sell
19,939
-2,891
-13% -$35.8K ﹤0.01% 1279
2025
Q3
$343K Buy
22,830
+2,065
+10% +$30.1K ﹤0.01% 1154
2025
Q2
$293K Sell
20,765
-1,203
-5% -$21.4K ﹤0.01% 1134
2025
Q1
$528K Buy
+21,968
New +$775K ﹤0.01% 974

Other funds holding BHVN

AssetMark Inc's BHVN Position: Q3 2026 in Review

AssetMark Inc reduced its Biohaven (BHVN) stake by 2.1% in Q3 2026, selling an estimated $5.51K and leaving 18,084 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #1422.

AssetMark Inc first reported a position in BHVN in Q1 2025 and has held it in 7 quarters since. The position peaked at $528K in Q1 2025. 99 funds tracked by Wall St. Rank hold BHVN as of Q3 2026.

  • AssetMark Inc held 18,084 shares of Biohaven worth $241K as of Q3 2026.
  • AssetMark Inc sold 381 Biohaven shares in Q3 2026, an estimated $5.51K.
  • Biohaven made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #1422 holding.
  • AssetMark Inc first reported a position in Biohaven in Q1 2025 and has held it in 7 quarters since.
  • AssetMark Inc's Biohaven position peaked at $528K in Q1 2025.
  • 99 funds tracked by Wall St. Rank held Biohaven as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.